The duration of human life, a fundamental measure of societal well-being, is a subject of continuous interest and rigorous ...

A landmark study finds waist-to-height ratio more effective than BMI in identifying obesity risk, as central fat levels rise ...

Explore Zepbound's "Changing the Threads" exhibit, which is redefining the stigma of obesity through powerful stories and ...

Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

This would not be the first time that public-health experts have prematurely celebrated the peak of America’s obesity crisis.

Robert F. Kennedy's central mission as Donald Trump's newly appointed health secretary is to Make America Healthy Again (MAHA ...

European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from ...

In 2026 patents on semaglutide (the active ingredient in Wegovy and Ozempic) will expire in large emerg­ing markets including ...

A wounded man lies in a muddy ditch, stripped of his uniform and too weak to stand. His ribs protrude beneath the chain of ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are ...